TITLE

As STAP Papers are Retracted, A Riken Researcher Mulls Stalling World-First Trial

AUTHOR(S)
Fox, Cynthia
PUB. DATE
July 2014
SOURCE
Bioscience Technology;7/2/2014, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that Riken Center for Developmental Biology (CDB) researcher Masayo Takahashi is considering suspending a part of a world-first clinical trial of induced pluripotent stem cell (iPSC). Topics discussed include the "Nature" journal's retraction of Riken CDB researchers Haruko Obokata and Shinya Yamanaka's studies claiming to make stimulus-triggered acquisition of pluripotency (STAP) stem cells from ordinary cells and some problems from the studies.
ACCESSION #
97487822

 

Related Articles

  • Induced Pluripotent Stem Cells. Wilson, Kitchener D.; Wu, Joseph C. // JAMA: Journal of the American Medical Association;4/28/2015, Vol. 313 Issue 16, p1613 

    The article discusses the 2006 discovery of a method for creating induced pluripotent stem cells (iPSCs) by Takahashi and Shinya Yamanaka and colleagues, which won Yamanaka a Nobel Prize in 2012. Topics include the use of pluripotency to regenerate human organs and tissues, the time consumption...

  • REWIND STEM CELLS, THEN FAST FORWARD. Coghlan, Andy // New Scientist;12/22/2012, Vol. 216 Issue 2896/2897, p21 

    The article discusses the development of a process to transform adult cells into a stem cell state, focusing on induced pluripotent stem cells reverted by the researcher Shinya Yamanaka and a clinical trial planned by the biotechnology company Advanced Cell Technology Inc.

  • One Japan Stem Cell Institute Soars, One Struggles. Fox, Cynthia // Bioscience Technology;Jun2014, p1 

    The article reports on Center for iPS Cell Research and Application (CiRA) Nobel Prize winner and scientist Shinya Yamanaka in Japan. It mentions his statement over their proposed clinical trials on induced pluripotent stem cells (IPSCs). It also notes the problem of his sister institute, the...

  • Japan stem-cell trial stirs envy. Reardon, Sara; Cyranoski, David // Nature;9/18/2014, Vol. 513 Issue 7518, p287 

    The article discusses the clinical trials of induced pluripotent stem (iPS) cells. It states that the iPS cells are created by using a patient's own tissue and by inserting them in an adult's DNA cells to reprogram the cells to an embryonic-like state. The therapy was pioneered by Shinya...

  • Stem cells cruise to clinic. Cyranoski, David // Nature;2/28/2013, Vol. 494 Issue 7438, p413 

    The article discusses a study in Japan which aims to prove the safety of induced pluripotent stem (iPS) cells in human trials. It mentions the plan of Japanese ophthalmologist Masayo Takahashi from the RIKEN Center for Developmental Biology in Kobe, Japan to submit her application for the study...

  • Nobel for stem cell trick...  // New Scientist;10/13/2012, Vol. 216 Issue 2886, p6 

    The article reports that cell scientists John Gurdon and Shinya Yamanaka were awarded the 2012 Nobel prize in physiology or medicine for their research into the reprogramming of mature cells into induced pluripotent stem cells (iPSCs) which can differentiate like embryonic stem cells.

  • Corrigendum: Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Lister, Ryan; Pelizzola, Mattia; Kida, Yasuyuki S.; Hawkins, R. David; Nery, Joseph R.; Hon, Gary; Antosiewicz-Bourget, Jessica; O'Malley, Ronan; Castanon, Rosa; Klugman, Sarit; Downes, Michael; Yu, Ruth; Stewart, Ron; Ren, Bing; Thomson, James A.; Evans, Ronald M.; Ecker, Joseph R. // Nature;10/2/2014, Vol. 514 Issue 7520, p126 

    A correction to the article "Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cell" that was published in the March 03, 2011 issue is presented

  • Advances in Induced Pluripotent Stem Cell Technologies. Pal, Rajarshi; Rao, Mahendra; Vemuri, Mohan C.; Verma, Paul; Dinnyes, Andras // Stem Cells International;2012, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the technological advancements in the field of induced pluripotent stem cells (iPSC).

  • What is the point of large-scale collections of human induced pluripotent stem cells? McKernan, Ruth; Watt, Fiona M // Nature Biotechnology;Oct2013, Vol. 31 Issue 10, p875 

    A letter to the editor is presented related to the study "What is the point of large-scale collections of human induced pluripotent stem cells" by Ruth McKernan and Fiona M Watt in October 2013 issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics